187 related articles for article (PubMed ID: 24312174)
1. Is the improvement of CF patients, hospitalized for pulmonary exacerbation, correlated to a decrease in bacterial load?
Deschaght P; Schelstraete P; Van Simaey L; Vanderkercken M; Raman A; Mahieu L; Van Daele S; De Baets F; Vaneechoutte M
PLoS One; 2013; 8(11):e79010. PubMed ID: 24312174
[TBL] [Abstract][Full Text] [Related]
2. Does bacterial density in cystic fibrosis sputum increase prior to pulmonary exacerbation?
Stressmann FA; Rogers GB; Marsh P; Lilley AK; Daniels TW; Carroll MP; Hoffman LR; Jones G; Allen CE; Patel N; Forbes B; Tuck A; Bruce KD
J Cyst Fibros; 2011 Sep; 10(5):357-65. PubMed ID: 21664196
[TBL] [Abstract][Full Text] [Related]
3. Application of quantitative PCR to the diagnosis and monitoring of Pseudomonas aeruginosa colonization in 5-18-year-old cystic fibrosis patients.
Billard-Pomares T; Herwegh S; Wizla-Derambure N; Turck D; Courcol R; Husson MO
J Med Microbiol; 2011 Feb; 60(Pt 2):157-161. PubMed ID: 20947668
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
[TBL] [Abstract][Full Text] [Related]
5. Reduction in Pseudomonas aeruginosa sputum density during a cystic fibrosis pulmonary exacerbation does not predict clinical response.
Lam JC; Somayaji R; Surette MG; Rabin HR; Parkins MD
BMC Infect Dis; 2015 Mar; 15():145. PubMed ID: 25887462
[TBL] [Abstract][Full Text] [Related]
6. 2-Alkyl-4-quinolone quorum sensing molecules are biomarkers for culture-independent
Zain NMM; Webb K; Stewart I; Halliday N; Barrett DA; Nash EF; Whitehouse JL; Honeybourne D; Smyth AR; Forrester DL; Knox AJ; Williams P; Fogarty A; Cámara M; Bruce KD; Barr HL
J Med Microbiol; 2021 Oct; 70(10):. PubMed ID: 34596013
[No Abstract] [Full Text] [Related]
7. Antibiotic perturbation of mixed-strain Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Tai AS; Sherrard LJ; Kidd TJ; Ramsay KA; Buckley C; Syrmis M; Grimwood K; Bell SC; Whiley DM
BMC Pulm Med; 2017 Nov; 17(1):138. PubMed ID: 29096618
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of viral respiratory tract infections on sputum bacterial density during CF pulmonary exacerbations.
Chin M; De Zoysa M; Slinger R; Gaudet E; Vandemheen KL; Chan F; Hyde L; Mah TF; Ferris W; Mallick R; Aaron SD
J Cyst Fibros; 2015 Jul; 14(4):482-9. PubMed ID: 25544473
[TBL] [Abstract][Full Text] [Related]
9. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
[TBL] [Abstract][Full Text] [Related]
10. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients.
Bjarnsholt T; Jensen PØ; Fiandaca MJ; Pedersen J; Hansen CR; Andersen CB; Pressler T; Givskov M; Høiby N
Pediatr Pulmonol; 2009 Jun; 44(6):547-58. PubMed ID: 19418571
[TBL] [Abstract][Full Text] [Related]
11. One time quantitative PCR detection of Pseudomonas aeruginosa to discriminate intermittent from chronic infection in cystic fibrosis.
Boutin S; Weitnauer M; Hassel S; Graeber SY; Stahl M; Dittrich AS; Mall MA; Dalpke AH
J Cyst Fibros; 2018 May; 17(3):348-355. PubMed ID: 29336943
[TBL] [Abstract][Full Text] [Related]
12. Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.
Reid DW; Carroll V; O'May C; Champion A; Kirov SM
Eur Respir J; 2007 Aug; 30(2):286-92. PubMed ID: 17504792
[TBL] [Abstract][Full Text] [Related]
13. Elevated exoenzyme expression by Pseudomonas aeruginosa is correlated with exacerbations of lung disease in cystic fibrosis.
Grimwood K; Semple RA; Rabin HR; Sokol PA; Woods DE
Pediatr Pulmonol; 1993 Mar; 15(3):135-9. PubMed ID: 8327274
[TBL] [Abstract][Full Text] [Related]
14. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
[TBL] [Abstract][Full Text] [Related]
15. Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study.
Mangiaterra G; Amiri M; Di Cesare A; Pasquaroli S; Manso E; Cirilli N; Citterio B; Vignaroli C; Biavasco F
BMC Infect Dis; 2018 Dec; 18(1):701. PubMed ID: 30587160
[TBL] [Abstract][Full Text] [Related]
16. [Physiopathology of cystic fibrosis and of infections associated to this disease].
Aramă SS; Aramă V; Cercel AS; Ion DA; Hristea A; Sotcan M
Pneumologia; 2007; 56(4):202-7. PubMed ID: 18320796
[TBL] [Abstract][Full Text] [Related]
17. Pseudomonas aeruginosa from cystic fibrosis patients: study using whole cell RAPD and antibiotic susceptibility.
Mereghetti L; Marquet-van der Mee N; Loulergue J; Rolland JC; Audurier A
Pathol Biol (Paris); 1998 May; 46(5):319-24. PubMed ID: 9769892
[TBL] [Abstract][Full Text] [Related]
18. Sputum changes associated with therapy for endobronchial exacerbation in cystic fibrosis.
Smith AL; Redding G; Doershuk C; Goldmann D; Gore E; Hilman B; Marks M; Moss R; Ramsey B; Rubio T
J Pediatr; 1988 Apr; 112(4):547-54. PubMed ID: 3127569
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of bacteriophages in the sputum of cystic fibrosis patients.
Saussereau E; Vachier I; Chiron R; Godbert B; Sermet I; Dufour N; Pirnay JP; De Vos D; Carrié F; Molinari N; Debarbieux L
Clin Microbiol Infect; 2014 Dec; 20(12):O983-90. PubMed ID: 24920209
[TBL] [Abstract][Full Text] [Related]
20. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
Martin LW; Robson CL; Watts AM; Gray AR; Wainwright CE; Bell SC; Ramsay KA; Kidd TJ; Reid DW; Brockway B; Lamont IL
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
